Our previous study has shown that PDPN hyperactivates the Wnt/β-catenin pathway in melanoma by stabilizing β-catenin, promoting its nuclear translocation and complex formation with LEF/TCF, and driving oncogenic transcriptional programs (19). The gene discussed is HNF4A; the disease is melanoma.